glp-1 receptor agonist antipsychotic weight gain study Agonists in Mood Disorders: A Psychiatric Perspective Frontiers | Metformin in the
Description
doi: 10.1016/j.ajpath.2019.10.008 89 ShaSLiuXZhaoRQingLHeQSunLet al
( SIDEBAR 1 )
Patient and public involvement No patient representatives or members of the public were directly involved in the planning, design, conduct, or reporting of this study, and no primary data were collected
35 , 713716 (2007) Underwood, C
safety evaluation continues in Phase 3 trials
Glucagon-like peptide-1 receptor agonists in non-alcoholic fatty liver disease: an update
